aminoimidazole carboxamide has been researched along with exenatide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayala, J; Ayala, JE; Burmeister, MA; Drucker, DJ | 1 |
Cai, M; Li, X; Liang, H; Wen, X; Weng, J; Xu, F; Zhang, Y | 1 |
2 other study(ies) available for aminoimidazole carboxamide and exenatide
Article | Year |
---|---|
Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anorexia; Antimetabolites; Appetite Regulation; Cell Line; Deoxyglucose; Drinking; Eating; Energy Metabolism; Exenatide; Fructose; Glucagon-Like Peptide-1 Receptor; Glucose; Hypoglycemic Agents; Hypothalamus; Male; Mice; Mice, Knockout; Motor Activity; Neurons; Peptides; Receptors, Glucagon; Ribonucleotides; Signal Transduction; Venoms | 2013 |
Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endometrial Neoplasms; Exenatide; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Peptides; Phosphorylation; Ribonucleotides; TOR Serine-Threonine Kinases; Venoms; Xenograft Model Antitumor Assays | 2016 |